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Objective. The main purpose of this study was to evaluate the associations of lifestyle medical advice and non-HDL cholesterol
control of a nationally representative US sample of adults with hypercholesterolemia by race/ethnicity. Methods. Data were
collected by appending sociodemographic, anthropometric, and laboratory data from two cycles of the National Health and
Nutrition Survey (2007-2008 and 2009-2010). This study acquired data from male and female adults aged≥ 20 years (N = 11,577),
classified as either Mexican American (MA), (n = 2173), other Hispanic (OH) (n = 1298), Black non-Hispanic (BNH)
(n = 2349), or White non-Hispanic (WNH) (n = 5737). Results. Minorities were more likely to report having received
dietary, weight management, and exercise recommendations by healthcare professionals than WNH, adjusting for confounders.
Approximately 80% of those receiving medical advice followed the recommendation, regardless of race/ethnicity. Of those who
received medical advice, reporting “currently controlling or losing weight” was associated with lower non-HDL cholesterol. BNH
who reported “currently controlling or losing weight” had higher non-HDL cholesterol than WNH who reported following
the advice. Conclusion. The results suggest that current methods of communicating lifestyle advice may not be adequate across
race/ethnicity and that a change in perspective and delivery of medical recommendations for persons with hypercholesterolemia
is needed.
1. Introduction
Cholesterol, the functional unit of numerous, essential
hormones and steroids in the human body, circulates
in blood. Even though cholesterol is necessary for body
function, elevated levels can result in atherosclerosis and
cardiovascular disease. Levels of serum cholesterol less
than 200mg/dL are considered in the healthy, normal
range; borderline cholesterol is 200–239mg/dL; elevated
blood cholesterol, 240mg/dL or above, is classified as high
cholesterol [1]. Primary goals of therapy and treatment
are focused on low-density lipoprotein cholesterol (LDL-
C) < 100mg/dL, where 130mg/dL is considered borderline
high [1]. Despite the decrease in LDL-C since the 1960s,
hypercholesterolemia, a key risk factor of atherosclerosis
and coronary heart disease, currently aﬀects nearly half
of the US adult population [2]. Hypercholesterolemia is a
metabolic disorder characterized by high levels of serum
cholesterol, particularly LDL-C. For treatment purposes,
hypercholesterolemia individually diagnosed based on high
LDL-C and concurrence of other cardiovascular disease
risk factors such as smoking, hypertension, diabetes, and a
family history of premature coronary heart disease [3]. The
recommended treatment of hypercholesterolemia involves
weight loss, dietary and physical activity changes, and a
possible medical regime. Prescription of LDL-C lowering
medications should be reserved for aggressive treatment
when LDL-C levels do not respond to dietary modifications
and increased exercise [3, 4]. The side eﬀects of statins, a
commonly prescribed cholesterol-lowing medication, may
outweigh their benefit for otherwise healthy adults [4].
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A diagnosis of hypercholesterolemia and consequent
treatment is only possible for adults who had adequate
medical care, which included blood collection for a lipid
panel. Among a nationally representative sample of US adults
in 2005-2006, aged 20 years or older, only three-quarters
reported ever having their cholesterol checked with lower
reports for Mexican Americans and non-Hispanic Blacks as
compared to non-Hispanic Whites [2]. Minorities have been
reported to have less access and quality of health care for
cholesterol screening and treatment [5]. Even when treated
for hypercholesterolemia, a lower percent of minorities
were prescribed dietary and exercise counseling, based on a
representative US sample of approximately 27 million adults,
aged ≥20 years, from a medical registry [5].
Because the initial treatment of hypercholesterolemia
involves dietary and physical activity changes, it is imperative
that the diagnosed individuals recall having received these
lifestyle medical recommendations. Therefore, the aim of
this study was to examine a US representative sample
of adults for the years 2007–2010 and to investigate the
following (1) the likelihood of lifestyle medical advice
received diﬀering by race/ethnicity for those adults who had
their cholesterol checked; (2) percents of adults given and
following medical advice; (3) the association of non-HDL
cholesterol with reporting following lifestyle medical advice.
2. Materials and Methods
2.1. Data Collection. All data used for this study were
approved by the research ethics board and publically
available from appended 2-year cycles of datasets from
the National Health and Nutrition Examination Survey
(NHANES) 2007-2008 and 2009-2010 [6]. NHANES uses
a complex, multistage, probability sample design to obtain
representative samples of the noninstitutionalized, civilian
US population [6]. This study acquired data from male and
female adults aged ≥20 years (N = 11, 577). The final
sample size for participants with hypercholesterolemia and
measurements of total and/or non-HDL cholesterol was 3325
(MA = 505; OH = 362; BNH = 614; WNH = 1844).
2.2. Major Variables. Hypercholesterolemia was considered an
aﬃrmative answer to “ever told by a doctor or other health
care professional that you had a high blood cholesterol level”.
Non-HDL cholesterol was constructed by subtracting HDL-
C from total cholesterol. Cholesterol control (yes/no) was
constructed as a binary variable with non-HDL cholesterol
<130mg/dL considered adequate control versus≥130mg/dL
as inadequate control. The number of participants with this
cutoﬀ was chosen based on the National Cholesterol Edu-
cation Program’s (NCEP-ATP III) guideline of 130mg/dL
for persons with >20% cardiovascular disease risk [1]
and the American Association of Clinical Endocrinologists’
(AACE) guidelines of non-HDL cholesterol as 30mg/dL
above the goal (<100mg/dL) for LDL-C [7]. Medical advice
(yes, no) for weight, diet, and exercise were the major
independent variables and phrased as follows: to lower your
blood cholesterol have you ever been told by your doctor
or other health professional to: (1) eat fewer high-fat or
high-cholesterol foods? (2) control weight or lose weight?
(3) increase physical activity or exercise?
2.3. Adjustment Variables. Comorbidities of hypercholes-
terolemia used in the analysis were coronary heart disease,
diabetes, and hypertension. Coronary heart disease was
defined as an aﬃrmative response to the question, “Has a
doctor or other health professional ever told you that you
had coronary heart disease?” Diabetes was considered an
aﬃrmative answer to the question, “Has a doctor or other
health care professional told you that you had diabetes or
sugar diabetes?” Having hypertension was defined as a sys-
tolic blood pressure ≥140mm Hg, a diastolic blood pressure
≥90mm Hg (using the average of first two readings), or
taking hypertension medication [8].
Obesity was estimated using the proxy measurement of
body mass index (BMI) and was calculated from measured
weight and height (kg/m2) and was categorized based on the
National Institutes of Health’s recommended levels: normal
weight (<24.9 kg/m2); overweight (24.9–29.9 kg/m2); obese
I (30.0–34.4 kg/m2); obese II or more (≥35 kg/m2) [9]. A
binary variable was created for current cigarette use versus
not currently smoking. Education was assessed as < high
school; high school diploma or general equivalency diploma;
> high school. Health insurance was defined as having any
coverage within the past 12 months (yes/no).
2.4. Statistical Analysis. Chi-square tests were performed
to determine hypercholesterolemia and medical advice by
ethnicity. Logistic regression analyses were conducted for
non-HDL cholesterol control as the outcome variable.
Reduced models included race/ethnicity adjusted for age
and gender. Fully adjusted models included the covariates
of the simple models along with: currently smoking, BMI,
education, health insurance, and lipid-lowering medication.
In addition, hypertension, diabetes, and coronary heart
disease were added to test medical advice received by
race/ethnicity. Adjusted sample weights were used to account
for unequal probabilities of selection and nonresponse in
the multistage stratified cluster sampling design used in
NHANES in order to achieve unbiased national estimates.
The sample weights used were based on the data file with the
smallest sample size, theMobile Examination Center (MEC),
and were computed using the average of the 2-year sample
weights for each cycle, as per guidelines set by NHANES [10].
Data analysis was conducted with complex module, IBM-
SPSS version 19. The Wald F statistic was used to determine
model significance for logistic regression analysis [11]. For
the chi-squared test, significance was based on the adjusted F
statistic, a variant of the second-order Rao Scott adjusted chi-
square statistic used for analyses with sample weights, where
df1 + df2 = 33 (total degrees of freedom).
3. Results
Key risk factors associated with hypercholesterolemia are
shown in Table 1. There were significant diﬀerences in major
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Table 1: Major hypercholesterolemia risk factors of the study population by race/ethnicity.
Variable MA OH BNH WNH P value
Cholesterol checked (yes) 51.2 (1.6)a 60.5 (2.2)b 69.7 (1.3)c 78.5 (0.9)d <.001
Inadequate non-HDL-C (≥130 mg/dL) 25.8 (2.0)a 22.1 (2.5)a 33.1 (2.1)b 30.6 (1.1)b .008
High cholesterol (≥200mg/dL) 45.9 (1.4)a 42.1 (2.2)a,b 39.7 (1.3)b 44.5 (0.9)a,b .019
Lipid-lowering medications (yes) 50.7 (3.4)− 44.1 (3.4)− 51.7 (1.8)− 54.7 (1.6)− .129
Age (years) 51.2 (1.2)a 52.3 (1.1)a,b 53.8 (0.5)b 57.4 (0.3)c <.001
Education: <HS 51.5 (1.6)a 37.7 (2.4)b 26.1 (1.7)c 13.8 (1.4)d <.001
No health insurance 52.2 (1.9)a 36.3 (3.1)b 26.0 (1.4)c 13.7 (0.7)d <.001
Current smoker 11.4 (1.1)a 14.5 (1.8)a 21.7 (1.7)b 19.1 (1.2)b <.001
BMI 30–34.9 (kg/m2) obesity I 22.5 (1.6)a 18.6 (1.4)b,c 21.6 (1.3)a,c 18.5 (0.6)b <.001
BMI ≥ 35(kg/m2) obesity II 18.0 (0.8)a 17.0 (1.3)a 26.1 (1.2)b 16.2 (0.6)a <.001
HTN (yes) 19.2 (1.4)a 21.1 (1.6)a 38.7 (1.3)b 31.8 (1.0)c <.001
Diabetes (yes) 8.4 (0.8)a 8.5 (0.8)a 13.5 (0.8)b 7.6 (0.6)c <.001
CHD (yes) 1.8 (0.3)a 1.4 (0.3)a 1.6 (0.2)a 3.7 (0.2)b <.001
MA: Mexican American; OH: other Hispanic, not Mexican; BNH: Black non-Hispanic; WNH: White non-Hispanic; non-HDL-C: non-HDL cholesterol (total
cholesterol minus HDL-C); BMI: body mass index; HTN: hypertension; CHD: coronary heart disease.
The data represent the weighted percent and standard error [% (SE)]. Significance is based on the adjusted F, a variant of the second-order Rao-Scott adjusted
chi-square statistic and its degrees of freedom. Each superscript letter denotes a subset of race/ethnicity categories whose column proportions do not diﬀer
significantly from each other at the 0.05 level for each row (variable). Significant diﬀerences between each group were measured by complex logistic regression
analyses across race/ethnicity separately for each dependent binary variable. Age was tested by complex general linear models, recoding ethnicity to measure
diﬀerences between groups.
sociodemographics, body mass index, morbidities, and
having cholesterol checks among race/ethnicity. WNH had
the highest prevalence of reporting having their cholesterol
checked followed by BNH, OH, and MA. For those with
hypercholesterolemia, coronary heart disease was higher in
WNH than other race/ethnicity categories. BNH, followed by
WNH, had higher prevalence of hypertension as compared
to Hispanics. BNH had a higher prevalence of obesity II
[BMI ≥ 35(kg/m2)] and diabetes than other groups. A lower
percent of minorities were covered by health insurance with
MA having the least coverage.
The likelihood of receiving medical advice by
race/ethnicity is shown in Table 2. Compared to WNH,
MA and BNH were more likely to be given advice to eat
fewer high-fat or –cholesterol foods. MA and OH were more
likely to be told to lose or control their weight as compared to
WNH. All Hispanics and BNH were more likely to be told to
increase physical activity or exercise as compared to WNH.
The percent of adults with hypercholesterolemia who
reported aﬃrmatively that they were given diet, weight, and
exercise medical advice to reduce their cholesterol levels
and who reported aﬃrmatively now following the advice is
shown in Table 3. Despite the fact that weight management
and increasing physical activity are vital recommendations
for individuals with hypercholesterolemia, approximately
40% and 30%, respectively, reported not receiving advice
for these lifestyle behaviors. The majority of the participants
(approximately 80%), who reported having received medical
advice, followed the corresponding recommendations.
Participants who responded aﬃrmatively to being given
medical advice for hypercholesterolemia were included in a
chi-squared test of whether they followed each recommen-
dation (yes/no) across non-HDL-C control (<130mg/dL,
yes/≥130mg/dL, no) (Table 3). Reporting now eating fewer
fatty foods (P = .002) and now losing weight (P = .005) were
significantly associated with the corresponding recommen-
dation. Cholesterol control (non-HDL-C < 130mg/dL) was
found for approximately two-thirds of those who reported
eating fewer fatty foods (67.5%, SE = 1.2%). Similarly, of
those participants who reported now controlling or losing
weight, 67.3% (SE = 1.4%) had cholesterol control (non-
HDL-C < 130mg/dL).
Reporting following medical recommendations for diet
and physical activity (yes/no) and non-HDL cholesterol
(continuous) was tested by a complex general linear model.
The model was significant; however, of the behaviors only
“now controlling or losing weight” was significant (data
not shown). Reduced and full models were constructed for
reporting “controlling or losing weight” by race/ethnicity
(Table 4). Lower non-HDL cholesterol levels were associated
with an aﬃrmative report of “now controlling or losing
weight” for the reduced model (adjusted only for age
and gender (P = .001)). For the fully adjusted model,
which included, BMI, health insurance, education, currently
smoking, and lipid-lowering medication(s), the 2-way inter-
action “controlling or losing weight” by race/ethnicity was
significant (P = .014) and the main eﬀect (controlling or
losing weight) was no longer significant (P = .998); however
race/ethnicity remained significant (P < .001). BNH who
reported “controlling or losing weight” had significantly
higher non-HDL cholesterol as compared to WNH (P =
.003).
Use of lipid-lowering medications did not negate the
association of losing weight with non-HDL cholesterol as a
continuous variable; however, for logistic regression models
lipid-lowering medications did negate the likelihood of hav-
ing cholesterol control (non-HDL cholesterol < 130mg/dL);
albeit the results were marginal [OR = 1.49 (1.18, 1.76),
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Table 2: Odds ratios for receiving medical advice by race/ethnicity.
Dependent variable Independent Model 1 Model 2 Model 3
Told to eat less fat
MA 1.48 (1.09, 2.04) 1.59 (1.14, 2.20) 1.60 (1.14, 2.26)
OH 1.10 (0.81, 1.48) 1.13 (0.82, 1.56) 1.15 (0.82, 1.60)
BNH 1.70 (1.36, 2.12) 1.59 (1.37, 1.99) 1.49 (1.19, 1.86)
WNH 1.00 1.00 1.00
Told to control or lose weight
MA 1.54 (1.12, 2.12) 1.58 (1.12, 2.21) 1.55 (1.07, 2.25)
OH 1.75 (1.33, 2.31) 1.77 (1.32, 2.39) 1.75 (1.26, 2.41)
BNH 1.37 (1.11, 1.70) 1.38 (1.11, 1.71) 1.21 (0.95, 1.54)
WNH 1.00 1.00 1.00
Told to exercise
MA 1.65 (2.23, 2.22) 1.64 (1.21, 2.23) 1.64 (1.20, 2.26)
OH 1.56 (1.20, 2.04) 1.56 (1.19, 2.06) 1.54 (1.15, 2.07)
BNH 1.71 (1.41, 2.08) 1.51 (1.24, 1.85) 1.35 (1.09, 1.68)
WNH 1.00 1.00 1.00
Model 1: adjusted for age and gender (and BMI for “told to control or lose weight”).
Model 2: adjusted for age, gender, BMI, current smoker, education, and health insurance.
Model 3: adjusted for age, gender, BMI, current smoker, education, health insurance, coronary heart disease, diabetes, and hypertension.
Table 3: Percent of adults given and following medical advice.
Given the recommendation to lower serum cholesterol
Percent given the advice who are
following the recommendation
SE
Told to eat less high-fat or high-cholesterol foods 81.8% (yes) 82.8 (80.7, 84.7) 1.0
Told to control weight or lose weight 59.4% (yes) 84.0 (81.3, 86.3) 1.2
Told to increase physical activity or exercise 69.9% (yes) 78.0 (75.4, 80.3) 1.2
Results are given as [mean (95% CI) SE].
with independents: race, gender, age, BMI, health insurance,
education, and smoking; OR = 1.18 (0.93, 1.49) with
the same independents and the additional covariate, lipid-
lowering medications] (data not shown).
4. Discussion
In a nationally representative population of adults with
hypercholesterolemia, we found discrepancies in medi-
cal advice for diet, weight management, and exercise by
race/ethnicity. Reporting having received medical advice
was associated with performing the recommended behavior;
yet, over one-third of adults across race/ethnicity with
hypercholesterolemia reported not receiving dietary, weight
management, or exercise recommendations by either their
physician or other health care professional. Moreover,
there were diﬀerences by race/ethnicity in reporting having
received these lifestyle recommendations. These results sug-
gest confounders such as patient-provider relationships and
health beliefs, which may vary by race/ethnicity and may
also influence interpretation of advice and resulting health
outcomes.
African Americans, as compared toWNHwith compara-
ble healthcare coverage, were found to have a poorer quality
of patient-provider relationships as well as poorer control of
cholesterol, in a national, multicentered prospective study
of patients with diabetes [12]. In the current study, BNH
who reported “controlling or losing weight” had significantly
higher non-HDL cholesterol as compared to WNH. This
disparity may be the result of diﬀerences in perceived
vulnerability or susceptibility by race/ethnicity. In this case,
BNH may not perceive danger of cardiac events until
their cholesterol level in a higher range than their WNH
counterparts.
The Agency for Health Care Research and Quality
(AHRQ) [13] calculated 70% disparity (worsening or no
improvement) between minorities and WNH with respect
to quality of care change in five years (from 2003 to 2008).
In contrast to the findings of Willson et al. [5], minorities
were more likely to receive medical advice than WNH in our
analysis; however, patient-provider relationships were not
assessed and may have confounded the results. It has been
suggested that physicians who positively engage minority
patients may either be members of a minority group or
have had experiences dealing with minority patient’s health
barriers andmay be acting in an attempt to reduce health dis-
parities [14]. Piette et al. [15] found that African Americans
and Spanish-speaking patients as well as patients with a lower
education reported having better communication with their
physicians than patients of other race/ethnicities. Conversely,
African American patients reported poorer patient-physician
communication as compared to Whites with the same
healthcare coverage in a national multicenter prospective
study [12]. The investigators found that health outcomes
and disease control had been positively associated with the
quality of patient-physician communication, as measured
by the patients’ trust and report of physicians listening,
explaining, showing respect, and spending time [12].
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Table 4: Eﬀect of reporting “now controlling or losing weight” on non-HDL cholesterol of those participants who were told to “control or
reduce weight” by race/ethnicity.
Independent variables
Model 1 Model 2
B (95% CI) SE B (95% CI) SE
Now controlling or losing weight (yes) −8.9 (−13, −4.5) 2.2∗ −4.4 (−8.4, −1.3) 1.8
MA 2.2 (−5.8, 10.2) 3.9 −1.1 (−9.1, 6.8) 3.9
OH −2.9 (−12, 6.5) 4.7 −3.8 (−12, 4.6) 4.1
BNH −16 (−22, −11) 2.8∗ −18 (24, 11) 3.2∗
Lose wt by MA 0.70 (−9.9, 11) 5.2 0.66 (−8.2, 9,5) 4.3
Lose wt by OH 9.7 (−0.32, 19) 4.9 5.0 (−4.0, 14) 4.4
Lose wt by BNH 15 (6.8, 23) 4.1∗ 14 (5.2, 22) 4.2∗
Model summary
R2 = 0.063 R2 = 0.21
F(9, 24) = 41.0, P < 0.001 F(17, 16) =58.7, P < 0.001
Non-HDL cholesterol: non-high-density lipoprotein cholesterol; MA: Mexican American; OH: other Hispanic; BNH: Black, non-Hispanic; wt: weight.
Model 1 was adjusted for gender and age. Model 2 included body mass index, health insurance, education, currently smoking, and taking cholesterol-lowering
medication(s) along with the adjustments of Model 1. White non-Hispanic (WNH) is the reference group for race/ethnicity. Significance (P < 0.05) is denoted
by (∗).
In the current study, there were no diﬀerences in LDL-
C managing behaviors among race/ethnicity for adults with
hypercholesterolemia given lifestyle medical advice. Instead,
being given medical recommendations was associated with
making the changes. These findings support the benefit of
secondary prevention measures of diet and exercise recom-
mendations by medical professionals. Several studies found
racial/ethnic diﬀerences in therapeutic lifestyle changes for
patients with chronic disease. BeLue et al. [16] reported dif-
ferent patterns of diet-exercise behavior (fruit and vegetable
intake, fat intake and exercise) by race/gender groups for
Black and White adults with hypercholesterolemia. Oster
et al. [17] reported that Blacks and Hispanics were less
likely to monitor their diet than WNH with diabetes in a
national managed care organization. Moreover, for patients
with diabetes, Blacks were less likely to exercise as compared
to Whites [17, 18].
Weight loss, but not reducing fatty foods nor increas-
ing physical activity, was associated with lower non-HDL
cholesterol in our study. Several meta-analyses of dietary
interventions for cardiovascular risk reduction have reported
modest eﬀects in cholesterol reduction [19–21]. Albeit, even
modest reductions in serum cholesterol, about 10%, have
been associated with a 50% decrease in the incidence of
coronary heart disease for age 40 and 20% for age 70 for
approximately 500,000 men in a meta-analysis of cohort
studies [22].
In order for serum non-HDL cholesterol management to
be eﬀective, several precursors are necessary: (1) access to
qualitymedical care that provides a diagnosis of hypercholes-
terolemia; (2) a culturally appropriate, nondiscriminatory
environment that encourages continuation of healthcare
utilization; and, (3) eﬀective patient-provider relationships
that involve patients in their treatment plans and empower
them to follow disease-specific recommendations. Barriers
for receiving and interpreting medical advice may diﬀer by
race/ethnicity. Based on a national survey of healthcare qual-
ity, African Americans, Hispanics, and Asians reported more
perceived healthcare provider discrimination than WNH
[23]. Poorer health status was associated with perceived
healthcare discrimination more frequently in minorities
than WNH [23]. There is inconclusive evidence regarding
diﬀerences in patient-provider communication among the
Hispanic subgroups. Although access to healthcare varies
among Hispanic groups [24], the diﬀerences in access were
not related to the quality of communication between the
patient and their healthcare provider [25].
Receiving advice may not be interpreted equally across
patients and may be a confounder in serum non-HDL
cholesterol control. In particular, the interpretation of the
medical recommendation to “eat fewer high-fat or high-
cholesterol foods” may not be consistent among patients
and may vary by race/ethnicity. Since people usually eat ad
libitum (until they are satisfied), they are likely to exchange
one food for another, rather than to reduce total calories [26].
In an eﬀort to reduce “fatty foods,” patients may substitute
any combination of the following: refined carbohydrates
(such as white flour or white rice), unrefined grains (such
as whole oats, wheat, or brown rice), or healthy fats (such
as nuts, seeds, avocados, and mono- and poly-unsaturated
oils) for “fatty foods.” The range of actions resulting in
the interpretation of this dietary advice may have been a
confounder in non-HDL cholesterol control.
Numerous prospective studies of both primary and
secondary preventive measures to reduce the prevalence of
hypercholesterolemia suggest that these eﬀorts may prove to
be beneficial by reducing its prevalence in the US. Healthy
adults followed for 27 years were 26% and 30% less likely to
develop hypercholesterolemia that maintained or increased
their fitness level, respectively, compared to those who lost
fitness levels [27]. Secondary prevention, aimed at non-HDL
cholesterol control for those with hypercholesterolemia,
also entails medical recommendations for diet, weight, and
physical activity; yet, research regarding the eﬃcacy of advice
with behavior changes and health outcomes for persons with
hypercholesterolemia is limited.
Our results should be interpreted with respect to the
study strengths and limitations. A major strength of this
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study was the use of a large, nationally representative dataset.
Another strength of this study was the use of non-HDL
cholesterol as both a binary and continuous variable to
measure cholesterol control as opposed to total cholesterol.
The use of non-HDL cholesterol <130mg/dL as adequate
control may not be a suitable goal for all persons with
hypercholesterolemia. The AACE guidelines are that goals
for non-HDL cholesterol be set at 30mg/dL above the target
for LDL-C [7]. Although a target of non-HDL cholesterol
<130mg/dL is recommended for most patients, guidelines
for lipid goals for patients at risk for coronary artery disease
vary by physician and should be set as 30mg/dL above the
patient’s LDL-C goals [7]. Several limitations were noted.
The category “Others” was not used due to a small sample
size. Data concerning having serum cholesterol checked and
being given medical advice to manage hypercholesterolemia
were self-reported and may contain some inaccuracies.
Moreover, bias by race/ethnicity, age, gender, or other
characteristics are possible due to recall diﬀerences among
people.
5. Conclusions
The findings of this study indicate a lack of congruence in
following medical advice and achieving adequate non-HDL
cholesterol control by race/ethnicity. These results suggest
that current methods of communicating lifestyle advice may
not be adequate across ethnicity/race and that a change
in perspective and delivery of medical recommendations
for persons with hypercholesterolemia is needed. Evaluation
of patient-provider communication with cholesterol man-
agement across race/ethnicity may be necessary to develop
eﬀective dietary and physical activity intervention strategies.
The results of our study may inform healthcare professionals
of the need to develop client-centered treatment plans with
clear, individualized goals for diet, weight management, and
physical activity.
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